Our Promise to you:
Premier global microbiological solutions, extensive collection of products.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Recently, state-of-art genetic engineering has increased the ability to alter oncolytic bacterial strains. Such alteration decreases bacteria side effects while increasing their therapeutic benefits for cancer. Our talented scientists would research closely with you to offer help in bacteria-based cancer therapy.
As a leader in oncolytic bacteria genome editing, Microbiosci provides a "one-stop shop" tailored to your gene research needs. We have expertise in gene knockout, knock-in/replacement and site-directed mutagenesis. Microbiosci is able to provide you the comprehensive oncolytic bacteria genome editing service, including traditional recombineering system, CRISPR/Cas 9 system and site-specific recombination system.